Martin Joyce

Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA.

Lucid Holdings LLC is a holding company which engages in the provision of market research technology services. It offers sample buyers of all shapes and sizes simplified access to programmatic sample. The company was founded by Patrick Comer in 2010 and is headquartered in New Orleans, LA.

BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA.

EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA.

Hepregen Corp. develops bioengineering solutions for drug development. Its products include human HepatoPac and HepatoMune, rat, monkey, dog and multi species HepatoPac. The company was founded by Bernadette C. Fendrock, Sangeeta N. Bhatia and Salman Khetani in 2007 and is headquartered in Medford, MA.